The primary care companion for CNS disorders
-
Prim Care Companion CNS Disord · Jan 2013
Educational impact of a psychiatric liaison in the medical intensive care unit: effects on attitudes and beliefs of trainees and nurses regarding delirium.
Despite high rates and increased risk of mortality, delirium remains underdiagnosed and a minimal focus of formal medical education. This is the first study to examine the educational impact of a psychiatric liaison on beliefs and knowledge about delirium among both nurses and residents. ⋯ Though introduction of a psychiatric liaison was very well received by clinical staff, we did not meaningfully affect the attitudes and beliefs of trainees and nurses regarding delirium. Robust and lasting changes in attitudes regarding delirium may require more intensive efforts involving longer intervention periods, greater rounding frequency, or additional didactic teaching.
-
Prim Care Companion CNS Disord · Jan 2013
Pain and pain catastrophizing among internal medicine outpatients with borderline personality symptomatology: a cross-sectional self-report survey.
The extant literature indicates that individuals with borderline personality disorder generally report higher levels of pain than individuals without this disorder. This study examined relationships between borderline personality symptomatology, pain, and pain catastrophizing (a related aspect of the pain experience). ⋯ Regardless of the measure used, individuals with borderline personality disorder symptomatology consistently demonstrated higher pain scores at all time points, as well as higher levels of pain catastrophizing.
-
Prim Care Companion CNS Disord · Jan 2013
ReviewDiagnosis and treatment of depression in patients with congestive heart failure: a review of the literature.
Major depressive disorder (MDD) can be challenging to diagnose in patients with congestive heart failure, who often suffer from fatigue, insomnia, weight changes, and other neurovegetative symptoms that overlap with those of depression. Pathophysiologic mechanisms (eg, inflammation, autonomic nervous system dysfunction, cardiac arrhythmias, and altered platelet function) connect depression and congestive heart failure. ⋯ At present, limited empirical data exist with regard to treatment of depression in the increasingly large population of patients with congestive heart failure. Evidence reveals that both psychotherapeutic treatment (eg, cognitive-behavioral therapy) and pharmacologic treatment (eg, use of the selective serotonin reuptake inhibitor sertraline) are safe and effective in reducing depression severity in patients with cardiovascular disease. Collaborative care programs featuring interventions that work to improve adherence to medical and psychiatric treatments improve both cardiovascular disease and depression outcomes. Depression rating scales such as the 9-item Patient Health Questionnaire should be used to monitor therapeutic efficacy.
-
Prim Care Companion CNS Disord · Jan 2013
Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial.
To investigate whether milnacipran is safe and effective in improving cognitive function in patients with fibromyalgia. ⋯ Milnacipran may have a potential role in the improvement of pain, disability, and mood. The effect of milnacipran on cognition in fibromyalgia needs further research.